Human interferon-gamma ELISPOT:
IFN-gamma specific spots produced by 4x10E5 human PBMC.
Stimulation: viral peptide pool (cat. no. CT370).
IFN-gamma specific spots produced by 4x10E5 human PBMC.
Stimulation: viral peptide pool (cat. no. CT370).
Catalogue Number
CT230-T2
Description
Human IFN-γ T cell ELISPOT kit - 2-plate
Price
€330.00
staining
Silver
Characteristics
Transparent
Contents
- coating antibodies
- biotinylated detector antibodies
- phi-labeled goat anti-biotin antibodies
- activator solutions
- Blocking stock solution
- Dilution buffer T
- Tween-20
- transparent ELISPOT plates with lids and cover slips
- detailed manual
References list
- Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
- Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients.
- Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches.
- HCV persistence and immune evasion in the absence of memory T cell help.
- Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes.
- Immunology of Diabetes Society T-Cell Workshop: HLA class II tetramer-directed epitope validation initiative.
- Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes.
- Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial.
- CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes.
- Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.
- Conserved hierarchy of helper T cell responses in a chimpanzee during primary and secondary hepatitis C virus infections.
- Analysis of anthrax and plague biowarfare vaccine interactions with human monocyte-derived dendritic cells.
- Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6.
- FTY720 treatment of kidney transplant patients: a differential effect on B cells, naïve T cells, memory T cells and NK cells.
- Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantation.
- Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.